| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $14.2M | +257.0% |
| SG&A Expense | $13.9M | +22.1% |
| Operating Income | -$65.1M | -300.0% |
| Income Tax | -$1.5M | — |
| Net Income | -$62.9M | -299.7% |
| EPS (Basic) | -$3.51 | -2.6% |
| EPS (Diluted) | -$3.51 | -2.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $12.9M | -25.7% |
| Current Assets | $13.7M | -25.2% |
| Total Assets | $62.2M | -41.3% |
| Current Liabilities | $5.7M | +31.1% |
| Total Liabilities | $7.8M | +1.1% |
| Stockholders' Equity | $54.4M | +689.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$22.3M | -12.5% |
| Investing Cash Flow | $0 | -100.0% |
| Financing Cash Flow | $17.8M | +12.8% |